NCT00830557 Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
| NCT ID | NCT00830557 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Islet Cell Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2000-10-01 |
| Primary Completion | 2027-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2000-10-01 with a primary completion date of 2027-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
Eligibility Criteria
* Known or suspected pancreas disease including: * pancreas adenocarcinoma * islet cell cancer * pancreatic cysts * pancreatitis (hereditary, acute, or chronic) * Next of kin of deceased participant who did not complete participation before passing away Exclusion Criteria: * Under the age of 18 * Unable to provide informed consent * Prison inmates
Contact & Investigator
Shounak Majumder, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT00830557 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Islet Cell Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00830557 currently recruiting?
Yes, NCT00830557 is actively recruiting participants. Contact the research team at pancreas@mayo.edu for enrollment information.
Where is the NCT00830557 trial being conducted?
This trial is being conducted at Phoenix, United States, Jacksonville, United States, Rochester, United States.
Who is sponsoring the NCT00830557 clinical trial?
NCT00830557 is sponsored by Mayo Clinic. The principal investigator is Shounak Majumder, MD at Mayo Clinic. The trial plans to enroll 20,000 participants.